 |
Diabetech - Diabetes Tech, Research, NewsAuthor: Justin Eastzer
We cover diabetes technology, news, research, and management tips through expert interviews and people with diabetes who use the tech. We cover all the insulin pump and continuous glucose monitor (CGM) updates, patient stories and news from every diabetes conference. Language: en Genres: Health & Fitness, Medicine Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
$11 Insulin for All? Inside the Nonprofit Rewriting U.S. Drug Prices
Episode 154
Monday, 20 April, 2026
I sit down with Allan Coukell, Civica's Chief of Government Affairs & Public Policy Officer, to explore how its nonprofit insulin model and California’s CalRx partnership are bringing low-cost insulin—priced around $11 per pen and $30 per vial—to people nationwide, with or without insurance. We break down how pharmacy benefit managers, rebates, and the current drug pricing system have kept insulin prices high, and what’s finally shifting. We also dive into the rise of biosimilar insulin and how this approach could transform drug affordability far beyond diabetes. Learn about the Eversense 365 CGM Learn about Omnipod 5 (today's sponsor)* Join the Diabetech Newsletter Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care. *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.
